Madrigal Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights

Go back to Madrigal Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights
(NASDAQ: MDGL) Delayed: 534.16 -6.92 (1.28%)
Previous Close $541.08    52 Week High $18.24 
Open $534.17    52 Week Low $6.60 
Day High $540.00    P/E N/A 
Day Low $526.67    EPS $0.00 
Volume 198,804